T-cell Lymphoblastic Lymphoma

DBCOND0040739Hemic and Lymphatic DiseasesImmune System Diseases

T-cell Lymphoblastic Lymphoma is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as
T-cell lymphoblastic lymphoma (T-LBL) · T-lymphoblastic Lymphoma · Lymphoblastic T-Cell Lymphoma
Classified under
Indicated drugs

Resolves to

Vocabularies
SNOMED CT128808004UMLSC1292758

What you can answer from here — as of October 25, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
1Structured indicationPopulation, line of therapy, route and combination as fields, not prose
Sign in
29Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Drug reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for T-cell Lymphoblastic Lymphoma share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In